Phase 3 Readout~month

Phase 3 Topline: Long-Term Open-Label Study to Assess the Safety and Efficacy of Vatiquinone in Patients With Friedre

Indication
Friedreich Ataxia

Other upcoming events for PTCT

Phase 3 ReadoutPhase 3 Topline: A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
Phase 3 ReadoutPhase 3 Topline: A Phase 3b Open-Label Study of Long-Term Neurocognitive Outcomes in Children With Phenylketonuria Tr
Patent ExpiryPatent/Exclusivity Expiry: COMETRIQ
Phase 3 ReadoutPhase 3 Topline: Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sar
Patent ExpiryPatent/Exclusivity Expiry: CABOMETYX

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: Long-Term Open-Label Study to Assess the Safety and Efficacy of Vatiquinone in Patients With Friedre — PTCT Phase 3 Readout | BioSniper